The document provides an overview of the Integrated Disease Surveillance Project (IDSP) in India. IDSP aims to establish a decentralized district-based system for surveillance of communicable and non-communicable diseases. Key aspects of IDSP include integrating existing disease surveillance, strengthening public health laboratories, using information technology, and developing human resources. IDSP implements syndromic, presumptive, and confirmed surveillance for various diseases. Information flows from the community level up through district, state, and national surveillance committees, which analyze data and coordinate response actions. New IDSP initiatives include an alert call center, e-learning modules, and a media scanning cell.
Integrated Disease Surveillance Project (IDSP) was launched by Hon’ble Union Minister of Health & Family Welfare in November 2004 for a period upto March 2010. The project was restructured and extended up to March 2012. The project continues in the 12th Plan with domestic budget as Integrated Disease Surveillance Programme under NHM for all States with Budgetary allocation of 640 Cr.
A Central Surveillance Unit (CSU) at Delhi, State Surveillance Units (SSU) at all State/UT head quarters and District Surveillance Units (DSU) at all Districts in the country have been established.
Objectives:
To strengthen/maintain decentralized laboratory based IT enabled disease surveillance system for epidemic prone diseases to monitor disease trends and to detect and respond to outbreaks in early rising phase through trained Rapid Response Team (RRTs)
Programme Components:
Integration and decentralization of surveillance activities through establishment of surveillance units at Centre, State and District level.
Human Resource Development – Training of State Surveillance Officers, District Surveillance Officers, Rapid Response Team and other Medical and Paramedical staff on principles of disease surveillance.
Use of Information Communication Technology for collection, collation, compilation, analysis and dissemination of data.
Strengthening of public health laboratories.
A decentralized system of disease surveillance for timely and effective public health action with a focus on functional integration of surveillance components of various vertical programmes.
The key objective of the programme is to strengthen/maintain decentralized laboratory based IT enabled disease surveillance system for epidemic prone diseases to monitor disease trends and to detect and respond to outbreaks in early rising phase through trained Rapid Response Team (RRTs).
Integrated Disease Surveillance Project (IDSP) was launched by Hon’ble Union Minister of Health & Family Welfare in November 2004 for a period upto March 2010. The project was restructured and extended up to March 2012. The project continues in the 12th Plan with domestic budget as Integrated Disease Surveillance Programme under NHM for all States with Budgetary allocation of 640 Cr.
A Central Surveillance Unit (CSU) at Delhi, State Surveillance Units (SSU) at all State/UT head quarters and District Surveillance Units (DSU) at all Districts in the country have been established.
Objectives:
To strengthen/maintain decentralized laboratory based IT enabled disease surveillance system for epidemic prone diseases to monitor disease trends and to detect and respond to outbreaks in early rising phase through trained Rapid Response Team (RRTs)
Programme Components:
Integration and decentralization of surveillance activities through establishment of surveillance units at Centre, State and District level.
Human Resource Development – Training of State Surveillance Officers, District Surveillance Officers, Rapid Response Team and other Medical and Paramedical staff on principles of disease surveillance.
Use of Information Communication Technology for collection, collation, compilation, analysis and dissemination of data.
Strengthening of public health laboratories.
A decentralized system of disease surveillance for timely and effective public health action with a focus on functional integration of surveillance components of various vertical programmes.
The key objective of the programme is to strengthen/maintain decentralized laboratory based IT enabled disease surveillance system for epidemic prone diseases to monitor disease trends and to detect and respond to outbreaks in early rising phase through trained Rapid Response Team (RRTs).
On 19 November 1985, GOI renamed EPI program, modifying the schedule as ‘Universal Immunization Program’ dedicated to the memory of Late Prime Minister Mrs Indira Gandhi.
UIP has two vital components: immunization of pregnant women against tetanus, and immunization of children
National Leprosy Eradication Programme (NLEP)Kavya .
Chronic infectious disease caused by Mycobacterium leprae.
It usually affects the skin and peripheral nerves
Long incubation period generally 5-7 years.
Classified as paucibacillary or multibacillary
permanent disability
Timely diagnosis and treatment of cases
On 19 November 1985, GOI renamed EPI program, modifying the schedule as ‘Universal Immunization Program’ dedicated to the memory of Late Prime Minister Mrs Indira Gandhi.
UIP has two vital components: immunization of pregnant women against tetanus, and immunization of children
National Leprosy Eradication Programme (NLEP)Kavya .
Chronic infectious disease caused by Mycobacterium leprae.
It usually affects the skin and peripheral nerves
Long incubation period generally 5-7 years.
Classified as paucibacillary or multibacillary
permanent disability
Timely diagnosis and treatment of cases
Coronary restenosis refers to the re-narrowing or reoccurrence of blockage in a coronary artery that has previously been treated with a procedure such as angioplasty and stent placement. Angioplasty is a procedure used to open narrowed or blocked arteries by inflating a balloon-like device to widen the artery, and a stent may be placed to help keep the artery open.
Restenosis can occur when the artery becomes narrowed again due to various factors, including the growth of scar tissue inside the artery, inflammation, or the formation of new plaque. Restenosis can lead to recurrent symptoms of chest pain (angina) or other complications.
To help prevent restenosis, doctors may recommend lifestyle changes such as quitting smoking, adopting a heart-healthy diet, exercising regularly, and taking medications to manage risk factors such as high cholesterol, high blood pressure, and diabetes. In some cases, additional treatments or procedures may be necessary to address restenosis, such as repeat angioplasty, stent placement, or bypass surgery. It's essential for individuals who have undergone coronary artery procedures to follow their healthcare provider's recommendations for monitoring and managing their heart health to reduce the risk of restenosis.
Arrhythmias are abnormal heart rhythms that can occur when the electrical impulses that coordinate the heartbeats are disrupted. There are different types of arrhythmias, including:
1. Atrial Fibrillation (AFib): This is the most common type of arrhythmia and occurs when the heart's upper chambers (atria) beat irregularly and out of sync with the lower chambers (ventricles).
2. Supraventricular Tachycardia (SVT): SVT is a fast heart rate originating above the ventricles, often in the atria.
3. Ventricular Tachycardia (VT): VT is a fast heart rate that starts in the heart's lower chambers (ventricles).
4. Ventricular Fibrillation (VFib): VFib is a life-threatening arrhythmia where the ventricles quiver instead of pumping blood effectively.
5. Bradycardia: This is a slow heart rate, usually below 60 beats per minute.
Arrhythmias can be caused by various factors, including heart disease, high blood pressure, diabetes, smoking, excessive alcohol consumption, stress, certain medications, and structural abnormalities in the heart. Some arrhythmias may not cause any symptoms, while others can lead to symptoms such as palpitations, dizziness, chest pain, shortness of breath, and fainting.
Treatment for arrhythmias depends on the type and severity of the condition. It may include lifestyle modifications, medications, medical procedures like cardioversion or ablation, or implantation of devices like pacemakers or implantable cardioverter-defibrillators (ICDs) to help regulate the heart's rhythm.
If you experience symptoms of an arrhythmia or have been diagnosed with one, it's important to work closely with your healthcare provider to determine the best treatment plan and management strategies to help control
The IDSP integrates communicable and non-communicable diseases. Common to both of them are their purpose in describing the health problem, monitoring trends, estimating the health burden and evaluating programmes for prevention and control.
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
3. Outline of Presentation
• What is Surveillance?
• IDSP
–
–
–
–
–
–
–
–
–
–
–
–
Phases of implementation
Components
Objectives
Classification of surveillance
Conditions under regular surveillance
Flow of information
Surveillance activities at each level
Surveillance committees at each level
Reporting
Surveillance action
Strengths
New initiatives
5. Surveillance
• Surveillance is defined as the ongoing systematic
collection, collation, analysis and interpretation of
data and dissemination of information to those who
need to know in order that action be taken.
6. Important information in surveillance
•
•
•
•
•
•
Who gets the disease?
How many get them?
Where they get them?
When they get them?
Why they get them?
What needs to be done?
7. Key elements of a surveillance system
•
•
•
•
•
•
Detection and notification of health events
Investigation and confirmation
Collection of data
Analysis and interpretation of data
Feedback and dissemination of results
Response – Action for prevention and control
9. Phases of implementation
• Phase I (2004-05)
– Madhya Pradesh, Andhra, Himachal, Karnataka, Kerala, Maharashtra,
Mizoram, Tamil Nadu & Uttaranchal
• Phase II (2005-06)
– Chattisgarh, Goa, Gujarat, Haryana, Orissa, Rajasthan, West Bengal,
Manipur, Meghalaya, Tripura, Chandigarh, Pondicherry, Nagaland,
Delhi
• Phase III (2006-07)
– UP, Bihar, J&K, Punjab, Jharkhand, Arunachal, Assam, Sikkim, A&N
Island, D&N Haveli, Daman & Diu, Lakshadweep
10. Components
• Integrating & decentralizing disease surveillance &
response mechanisms
• Strengthening Public Health Laboratories
• Using Information Technology and Networking in disease
surveillance
• Human Resource Development
11. Objectives
• To establish a decentralized district based system of
surveillance for communicable and non-communicable
diseases, so that timely and effective public health actions can
be initiated in response to health changes in the urban and rural
areas
• To integrate existing surveillance activities to avoid
duplication and facilitate sharing of information across all
disease control programmes and other stake holders, so that
valid data is available for health decision making in the
district, state and national levels
12. What is integration?
• Sharing of surveillance information of various disease control
programmes
• Developing effective partnership with heath and non health
sectors in surveillance
• Including communicable and non communicable diseases in
the surveillance system
• Working with the private sector and non governmental
organization
• Bringing academic institutions and medical colleges into
disease surveillance
13. Classification of surveillance in IDSP
• Syndromic
– Diagnosis made on the basis of clinical pattern by
paramedical personnel and members of community
• Presumptive
– Diagnosis is made on typical history and clinical
examination by medical officers
• Confirmed
– Clinical diagnosis confirmed by appropriate laboratory
identification
14. Conditions under regular surveillance
Type of disease
Disease
Vector borne diseases
Malaria
Water borne diseases
Diarrhoea, Cholera, Typhoid
Respiratory diseases
Tuberculosis
Vaccine preventable diseases
Measles
Disease under eradication
Polio
Other conditions
Road traffic accidents
International commitment
Plague
Unusual syndromes
(Causing death/hospitalization)
Meningo-encephalitis
Respiratory distress
Hemorrhagic fever
Other undiagnosed condition
15. Other conditions under surveillance
Type of surveillance
Sentinel surveillance
Categories
Conditions
HIV/HBV/HCV
Other
conditions
Regular periodic surveys
STDs
Water quality
Noncommunicable
disease risk
factors
Anthropometry
Physical activity
Blood pressure
Tobacco, blood pressure
Outdoor air quality
Nutrition
Blindness
Additional state priorities
Up to five diseases
19. Information flow of the weekly
surveillance system
Sub-centres
Programme
officers
C.S.U.
S.S.U.
P.H.C.s
C.H.C.s
Pvt. practitioners
D.S.U.
Dist. hosp.
Nursing homes
Private hospitals
Med. col.
Private labs.
P.H. lab.
Other Hospitals:
ESI, Municipal
Rly., Army etc.
Corporate
hospitals
20. Surveillance activities at each level
Activities
Periphery
District
State
+++
++
-
Consolidation of data
+
+++
+++
Analysis and interpretation
+
+++
+++
+++
+++
+
Feedback
+
+++
++
Dissemination
+
++
++
Action
++
+++
+
Detection and notification of
cases
Investigation and confirmation
21. District Surveillance Committee
District Program Manager
Polio, Malaria, TB, HIV - AIDS
CMO
(Co. Chair)
Representative
Water Board
Chief District PH
Laboratory
Superintendent
Of Police
District Data Manager
(IDSP)
Chairperson*
District Surveillance Committee
Representative
Pollution Board
IMA
Representative
NGO
Representative
District Training Officer
(IDSP)
Medical College
Representative
if any
District Panchayat
Chairperson
District Surveillance Officer
(Member Secretary)
* District Collector or District Magistrate
22. State surveillance committee
Director Public
Health (Co. Chair)
Director Medical Education
Director Health Service
Representative
Water Board
State Program Managers
Polio, Malaria, TB, HIV - AIDS
NGO
State Data Manager IDSP
Chairperson*
State surveillance committee
Medical Colleges
State Coordinator
Head, State Public
Health Lab
Representative
Department of Home
State Training Officer
Representative
Department of Environment
* State health secretary
IMA
Representative
State Surveillance Officer
(Member Secretary)
23. National surveillance committee
Director General
Health Services
(Co. Chair)
Director General
ICMR
PD
(IDSP)
National Program Managers
Polio, Malaria, TB, HIV - AIDS
JS
(Family Welfare)
Chairperson*
National surveillance
committee
IMA
Representative
Director
NICD
NGO
Director
NIB
Consultants
(IndiaCLEN / WHO
/ Medical College
/others)
Representative
Ministry of Environment
* Secretary health and secretary family welfare
Representative
Ministry of Home
National Surveillance Officer
(Member Secretary)
24. Linkages of the central surveillance unit at the
central level
W.H.O.
Outbreak investigation
and rapid response
E.M.R.
NCDC
Non-communicable
diseases
surveillance
MIS and report
CSU
ICMR
NVBDCP
RNTCP
National
Programs
CBHI
RCH
Programme monitoring
NACP
25. Reporting
Reporting Forms
• Form ‘S’ (Suspect Cases)
• Health Workers (Sub Centre)
• Form ‘P’ (Probable Cases)
• Doctors (PHC, CHC, Pvt. Hospitals)
• Form ‘L’ (Lab Confirmed Cases)
• Laboratories
26.
27.
28.
29. Laboratory Reporting
Form
Level of Laboratory
Responsibility of
Reporting
Form L1 Peripheral Laboratory at PHC/CHC
Laboratory
Assistants/Technician
through MO I/c
Form L2 District Public Health Laboratory,
Labs of District Hospital, Private
and other Hospitals & Private Labs.
I/c
Microbiologist/Pathologists
Form L3 Labs in Medical Colleges, other
tertiary institutions,
Reference Labs.
Head, Microbiologist
Department
30. Warning Signals of an impending outbreak
• Clustering of cases/deaths in Time/Place
• Unusual increase in cases/ deaths
• Even a single case of measles , AFP, Cholera, Plague,
Dengue, or JE
• Ac. febrile illness of unknown etiology
• Two or more epidemiologically linked cases of outbreak
potential
• Unusual isolates
• Shifting in age
• High or sudden increase in vector density
• Natural Disaster
31. Surveillance Action
Preset trigger level with specific response for various levels
• Trigger Level 1 - Suspected limited outbreak
– local response
• Trigger Level 2 - Epidemic
– local & regional response
• Trigger Level 3 - Wide spread Epidemic
– local, regional & state level response
32. Strengths of IDSP - 1
1.
Functional integration of surveillance components of
vertical programmes
2. Reporting of suspect, probable and confirmed cases
(Standard case Definition)
3. Strong IT component for data analysis
4. Trigger levels for graded response
5. Action component in the reporting formats
6. Streamlined flow of funds to the districts
7. Standard Formats, Operations & Training Manuals
8. Involvement of Private Sector
33. New Initiatives - 1
1. Alerts through IDSP call center
Call Centre operational with 1075 toll free number since
February 2008
2. E-learning
The objective of e-learning is to enhance the skills to a wide
arena of health personnel.
Proposed components:
– Discussion Forums
– Online Survey & Assessment
– Feedback
– FAQs
Currently e-learning modules are being prepared
34. New Initiatives - 2
3. Media Scanning Cell
• Objective:
– To provide the supplemental information about outbreaks
• Method:
– National and local newspapers, Internet surfing, TV
channel screening for news item on disease occurrence.
• Benefits of Media Scanning:
– Increases the sensitivity & strengthen the surveillance
system
– Provide early warning of occurrence of clusters of diseases